S85715 |
4-Methyl-2-(1-piperidinyl)-quinoline |
源葉(MedMol) | ≥98% (HPLC) |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述: ML204 is a potent, selective TRPC4/TRPC5 channel inhibitor, with at least 19-fold selectivity against TRPC6 and no appreciable effect on all other TRP channels, nor on voltage-gated sodium, potassium, or Ca2+ channels
- 靶點(diǎn): TRPC4;TRPC5;TRP/TRPVChannel
- 體內(nèi)研究:
ML204 (1?mg/kg; s.c.; twice a day; for 5 days) causes mortality associated with exacerbated hypothermia and decreases peritoneal leukocyte numbers and cytokines in LPS-injected mice Animal Model: Nonfasted male C57BL/6 (2-3 months) Dosage: 1?mg/kg Administration: Subcutaneous injection, twice a day, for 5 days (prior to LPS injection) Result: Induced mortality associated with increased hypothermia in mice with LPS-induced systemic inflammatory response.
- 參考文獻(xiàn):
1. Miller M, et al. Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels. J Biol Chem. 2011 Sep 23;286(38):33436-46. 2. Miller MR, et al. Novel Chemical Inhibitor of TRPC4 Channels. Probe Reports from the NIH Molecular Libraries Program [Internet]. 3. Thomas Schaldecker, et al. Inhibition of the TRPC5 ion channel protects the kidney filter. J Clin Invest. 2013 Dec 2; 123(12): 5298–5309. 4. Domingos M S Pereira, et al. Transient Receptor Potential Canonical Channels 4 and 5 Mediate Escherichia coli-Derived Thioredoxin Effects in Lipopolysaccharide-Injected Mice. Oxid Med Cell Longev. 2018 Jun 10;2018:4904696.
- 溶解性: Soluble in DMSO、Ethanol
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 4.419 ml 22.093 ml 44.185 ml 5 mM 0.884 ml 4.419 ml 8.837 ml 10 mM 0.442 ml 2.209 ml 4.419 ml 50 mM 0.088 ml 0.442 ml 0.884 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)